Team:Paris/August 22

From 2008.igem.org

(Difference between revisions)
(Transformation of ligations from August 20th)
(Transformation of the ligations we did yesterday)
 
(15 intermediate revisions not shown)
Line 73: Line 73:
|'''measured size'''
|'''measured size'''
|
|
-
|'''1 kb'''<br>3 kb
+
|style="background: #ff6d73" |'''1 kb'''<br>3 kb
|
|
-
|0,3 kb<br>1,8 kb
+
|style="background: #ff6d73" |0,3 kb<br>1,8 kb
-
|0,3 kb<br>1,8 kb
+
|style="background: #cbff7B"| 0,3 kb<br>1,8 kb
-
|0,9 kb<br>2 kb
+
|style="background: #ff6d73" |0,9 kb<br>2 kb
-
|2 kb
+
|style="background: #ff6d73" |2 kb
-
|2 kb
+
|style="background: #ff6d73" |2 kb
|
|
|}
|}
-
<br>'''Results''': The clones tested didn't have the insert.
+
 
 +
'''Results''': The clones tested didn't have the insert.
 +
 
='''Construction of pFlgA - GFP Generator'''=
='''Construction of pFlgA - GFP Generator'''=
Line 180: Line 182:
| -
| -
|}
|}
 +
='''Construction for FIFO'''=
='''Construction for FIFO'''=
Line 202: Line 205:
|-
|-
|L161
|L161
-
|D167 (FV) + D1132 (FI)<br>pFlgA - YFP  tripart (LVA+)
+
|D167 (FV) + D132 (FI)<br>pFlgA - YFP  tripart (LVA+)
|Amp
|Amp
|-
|-
Line 303: Line 306:
-
=Promoter characterization plasmids=
+
='''Promoter characterization plasmids'''=
==Transformation of ligations from August 20th==
==Transformation of ligations from August 20th==
-
 
-
Top 10 cells were used
 
-
 
-
 
[[Team:Paris/Notebook/Protocols#Transformation |Protocol]]
[[Team:Paris/Notebook/Protocols#Transformation |Protocol]]
-
a changer
+
'''Top 10 cells were used'''
{|border="1" style="text-align: center"
{|border="1" style="text-align: center"
Line 318: Line 317:
|'''Vector digestion'''
|'''Vector digestion'''
|'''Vector description'''
|'''Vector description'''
-
|'''Vector volume'''
+
|'''Vector (µg/mL)'''
 +
|'''V. Vector (µl)'''
|'''Insert digestion'''
|'''Insert digestion'''
|'''Insert description'''
|'''Insert description'''
-
|'''Insert volume'''
+
|'''Insert (µg/mL)'''
 +
|'''V. Insert (µl)'''
|'''Product description'''
|'''Product description'''
|'''Antibiotic'''
|'''Antibiotic'''
Line 328: Line 329:
|D164
|D164
|J23101 promoter
|J23101 promoter
-
|10
+
|3
 +
|16
|D163
|D163
|gfp generator
|gfp generator
-
|2
+
|14
 +
|8
|J23101 promoter-gfp generator
|J23101 promoter-gfp generator
|Amp
|Amp
Line 338: Line 341:
|D161
|D161
|pTet promoter
|pTet promoter
-
|1
+
|39
 +
|1.25
|D163
|D163
|gfp generator
|gfp generator
-
|4
+
|14
 +
|5
|pTet promoter-gfp generator
|pTet promoter-gfp generator
|Kana
|Kana
|-
|-
-
|
+
|Control L156
|D161
|D161
|
|
-
|1
+
|
 +
|1.25
 +
|none
|
|
|
|
Line 358: Line 365:
|D125.2
|D125.2
|B0015
|B0015
 +
|15
|3
|3
|D162
|D162
-
|4
 
|tetR
|tetR
 +
|11
 +
|4
|tetR-B0015
|tetR-B0015
|Kana
|Kana
Line 367: Line 376:
|Control L157
|Control L157
|D125.2
|D125.2
 +
|
|
|
|3
|3
 +
|none
|
|
|
|
Line 378: Line 389:
|D185
|D185
|RBS B0032
|RBS B0032
 +
|21
|2
|2
|D182
|D182
|tetR
|tetR
 +
|10
|6.5
|6.5
|RBS B0032 - tetR
|RBS B0032 - tetR
Line 387: Line 400:
|Control L166
|Control L166
|D185
|D185
-
|RBS B0032
+
|
 +
|
|2
|2
|none
|none
 +
|
|
|
|
|
Line 398: Line 413:
|D181
|D181
|pTet
|pTet
 +
|1
|14
|14
|D184
|D184
|gfp generator
|gfp generator
 +
|14
|3
|3
|gfp generator - pTet
|gfp generator - pTet
Line 408: Line 425:
|D181
|D181
|pTet
|pTet
 +
|
|14
|14
|none
|none
 +
|
|
|
|
|

Latest revision as of 00:54, 21 September 2008

← Yesterday

↓ Calendar ↑

Tomorrow →

Contents

Analysis of the transformant of FlhDC+promotor

  • Analysis of the plasmids MP160.1 and MP160.2 (FlhDC+promotor in pSB1A2)
  • Control: MP143 (GFP generator in pSB1A2)

PCR

PCR screening programm
elongation time: 1 min 30
total volume reaction (25 µL)

  • 12,5 µL Quick load PCR Mix 2X
  • 0,5 µL O18
  • 0,5 µL O19
  • 1 µL DNA
  • 10,5 µL water

Digestion

total volume reaction (30 µL)

  • 2 µL DNA
  • 3 µL buffer 2 10X
  • 0,3 µL BSA 100X
  • 1 µL XbaI
  • 1 µL SpeI
  • 22,7 µL water

Incubation 2h55 at 37°C and then 20 min at 65°C.

Electrophoresis

KR000219.jpg
  • 1% agarose gel
  • for PCR products: 10 µL loaded
  • for digestion products (30 µL): adding of 7 µL of loading blue and then 20 µL loaded on gel
well n° 1 2 3 4 5 6 7 8 9
method PCR digestion
sample 1 kb DNA ladder positive control MP143 negative control MP160.1 MP160.2 MP143 MP160.1 MP160.2 100 bp DNA ladder
expected size 1114 bp 1403 bp 876 bp (E0240)
2079 (pSB1A2)
1165 bp (FlhDC+promotor)
2079 bp (pSB1A2)
measured size 1 kb
3 kb
0,3 kb
1,8 kb
0,3 kb
1,8 kb
0,9 kb
2 kb
2 kb 2 kb


Results: The clones tested didn't have the insert.


Construction of pFlgA - GFP Generator

Aim : Construction of "pFlgA-RBS-GFP-dbl ter" (pFlgA-E0240) Part icon regulatory.pngPart icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png

Digestion

Digestion

Protocol Digestion

Name Template DNA Description Vol MP (µl) Vol H2O (µl) Enzymes
D168 MP143.1 RBS - GFP - term (FV) 7.25 17.45 EcoRI and XbaI

Gel Extraction

Protocol

Gel Extraction of D168
Well 1 2 3 4 5 6
Sample 100 pb ladder MP143.1 no sample D168 no sample
Expected size (pb) 2 940
Measured size (pb) 5.000 3 000

Measurement of the concentration of D168 purified

Protocol (it's same that for Miniprep)

Digestion Name Concentration (µg/mL) Ratio 260/280
D168 24 2.15

Ligation

Protocol

Ligation Name Vector Name Volume Vector (µL) Insert Volume Insert (µL)
L164 D168 1.67 D132 2.04
Control L164 D168 1.67 - -


Construction for FIFO

Aim : Construction of pFlgA - YFP tripart (+/- LVA) "pFlgA-RBS-YFP-dbl ter" (pFlgA-E0430/E0432) Part icon regulatory.pngPart icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png

Transformation of the ligations we did yesterday

Protocol

Ligation Name Description Antibio
L160 D166 (FV) + D132 (FI)
pFlgA - YFP tripart (LVA-)
Amp
TL160 D166
YFP tripart (LVA-)
Amp
L161 D167 (FV) + D132 (FI)
pFlgA - YFP tripart (LVA+)
Amp
TL161 D167
YFP tripart (LVA+)
Amp

Construction for synchronization

Transformation of the ligations we did yesterday

Protocol

Ligation Name Description Antibio
L158 D110 (BV) + D131 (BI) Amp
Control L158 D110 Amp
L159 D125 (FV) + D109 (FI) Kan
Control L159 D125 Kan

Ligation

Protocol

Ligation Name Description Vector Name Volume vector (µL) Insert Name Volume insert (µL)
L162 rbs-lasI + gfp generator
Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.pngPart icon terminator.png
D107 (BV) 10 D163 (BI) 3.46
Control L162 autoligation control D107 (BV) 10 - -
L163 rbs-TetR + gfp generator
Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.pngPart icon terminator.png
D110 (BV) 2.5 D163 (BI) 3.44
Control L163 autoligation control D110 (BV) 2.5 - -

Transformation

Protocol

Ligation Name Description Antibio
L162 D107 (BV) + D163 (BI) Amp
Control L162 D107 Amp
L163 D110 (BV) + D163 (BI) Amp
Control L163 D110 Amp


Promoter characterization plasmids

Transformation of ligations from August 20th

Protocol

Top 10 cells were used

Ligation name Vector digestion Vector description C° Vector (µg/mL) V. Vector (µl) Insert digestion Insert description C° Insert (µg/mL) V. Insert (µl) Product description Antibiotic
L155 D164 J23101 promoter 3 16 D163 gfp generator 14 8 J23101 promoter-gfp generator Amp
L156 D161 pTet promoter 39 1.25 D163 gfp generator 14 5 pTet promoter-gfp generator Kana
Control L156 D161 1.25 none Vector autoligation control Kana
L157 D125.2 B0015 15 3 D162 tetR 11 4 tetR-B0015 Kana
Control L157 D125.2 3 none Vector autoligation control Kana
L166 D185 RBS B0032 21 2 D182 tetR 10 6.5 RBS B0032 - tetR Amp
Control L166 D185 2 none Vector autoligation control Amp
L167 D181 pTet 1 14 D184 gfp generator 14 3 gfp generator - pTet Amp
Control L167 D181 pTet 14 none Vector autoligation control Amp